Review



enhancer regions  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Addgene inc enhancer regions
    Enhancer Regions, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/enhancer regions/product/Addgene inc
    Average 90 stars, based on 2 article reviews
    enhancer regions - by Bioz Stars, 2026-03
    90/100 stars

    Images



    Similar Products

    95
    TaKaRa mouse ass1 enhancer region
    ( A ) Blood glucose levels in ICR mice with hepatic <t>Ass1</t> knockdown (n = 4 per group). ( B - G ) Plasma levels of urea cycle related amino acids, urea, and ammonia (NH3) in ICR mice with hepatic Ass1 knockdown (n = 4 per group). ( H ) Immunoblot analysis of Ass1 protein using liver total lysate from mice in the fasted state (Samples were pooled from 3 mice). GAPDH was detected as an internal loading control. ( I - Q ) Relative gene expression in ICR mice with hepatic Ass1 knockdown (n = 4 per group). Ass1 knockdown was performed using adenovirus mediated RNAi (Ad- Ass1 i-1, Ad- Ass1 i-2). As the correction of the gene expression level for each sample Cyclophilin A was used. All groups of mice were sacrificed at the same period in the light cycle and blood and liver samples were collected in the fasted state following 24-h fasting. All values are presented as the mean with error bars representing the SEM. Datasets were assessed by Student’s t -test for unpaired samples. The differences were considered to be significant if P < 0.05 (* P < 0.05 and ** P <0.01).
    Mouse Ass1 Enhancer Region, supplied by TaKaRa, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse ass1 enhancer region/product/TaKaRa
    Average 95 stars, based on 1 article reviews
    mouse ass1 enhancer region - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    95
    TaKaRa putative enhancer region
    ( A ) Blood glucose levels in ICR mice with hepatic <t>Ass1</t> knockdown (n = 4 per group). ( B - G ) Plasma levels of urea cycle related amino acids, urea, and ammonia (NH3) in ICR mice with hepatic Ass1 knockdown (n = 4 per group). ( H ) Immunoblot analysis of Ass1 protein using liver total lysate from mice in the fasted state (Samples were pooled from 3 mice). GAPDH was detected as an internal loading control. ( I - Q ) Relative gene expression in ICR mice with hepatic Ass1 knockdown (n = 4 per group). Ass1 knockdown was performed using adenovirus mediated RNAi (Ad- Ass1 i-1, Ad- Ass1 i-2). As the correction of the gene expression level for each sample Cyclophilin A was used. All groups of mice were sacrificed at the same period in the light cycle and blood and liver samples were collected in the fasted state following 24-h fasting. All values are presented as the mean with error bars representing the SEM. Datasets were assessed by Student’s t -test for unpaired samples. The differences were considered to be significant if P < 0.05 (* P < 0.05 and ** P <0.01).
    Putative Enhancer Region, supplied by TaKaRa, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/putative enhancer region/product/TaKaRa
    Average 95 stars, based on 1 article reviews
    putative enhancer region - by Bioz Stars, 2026-03
    95/100 stars
      Buy from Supplier

    90
    Beijing SyngenTech Co single-guide rnas (sgrnas) targeting enhancer regions around the foxf2 genomic locus
    ( A ) Blood glucose levels in ICR mice with hepatic <t>Ass1</t> knockdown (n = 4 per group). ( B - G ) Plasma levels of urea cycle related amino acids, urea, and ammonia (NH3) in ICR mice with hepatic Ass1 knockdown (n = 4 per group). ( H ) Immunoblot analysis of Ass1 protein using liver total lysate from mice in the fasted state (Samples were pooled from 3 mice). GAPDH was detected as an internal loading control. ( I - Q ) Relative gene expression in ICR mice with hepatic Ass1 knockdown (n = 4 per group). Ass1 knockdown was performed using adenovirus mediated RNAi (Ad- Ass1 i-1, Ad- Ass1 i-2). As the correction of the gene expression level for each sample Cyclophilin A was used. All groups of mice were sacrificed at the same period in the light cycle and blood and liver samples were collected in the fasted state following 24-h fasting. All values are presented as the mean with error bars representing the SEM. Datasets were assessed by Student’s t -test for unpaired samples. The differences were considered to be significant if P < 0.05 (* P < 0.05 and ** P <0.01).
    Single Guide Rnas (Sgrnas) Targeting Enhancer Regions Around The Foxf2 Genomic Locus, supplied by Beijing SyngenTech Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/single-guide rnas (sgrnas) targeting enhancer regions around the foxf2 genomic locus/product/Beijing SyngenTech Co
    Average 90 stars, based on 1 article reviews
    single-guide rnas (sgrnas) targeting enhancer regions around the foxf2 genomic locus - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Addgene inc enhancer regions
    ( A ) Blood glucose levels in ICR mice with hepatic <t>Ass1</t> knockdown (n = 4 per group). ( B - G ) Plasma levels of urea cycle related amino acids, urea, and ammonia (NH3) in ICR mice with hepatic Ass1 knockdown (n = 4 per group). ( H ) Immunoblot analysis of Ass1 protein using liver total lysate from mice in the fasted state (Samples were pooled from 3 mice). GAPDH was detected as an internal loading control. ( I - Q ) Relative gene expression in ICR mice with hepatic Ass1 knockdown (n = 4 per group). Ass1 knockdown was performed using adenovirus mediated RNAi (Ad- Ass1 i-1, Ad- Ass1 i-2). As the correction of the gene expression level for each sample Cyclophilin A was used. All groups of mice were sacrificed at the same period in the light cycle and blood and liver samples were collected in the fasted state following 24-h fasting. All values are presented as the mean with error bars representing the SEM. Datasets were assessed by Student’s t -test for unpaired samples. The differences were considered to be significant if P < 0.05 (* P < 0.05 and ** P <0.01).
    Enhancer Regions, supplied by Addgene inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/enhancer regions/product/Addgene inc
    Average 90 stars, based on 1 article reviews
    enhancer regions - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Jackson Laboratory mice expressing a cre recombinase under the control of the itgax promoter/enhancer region b6.cg-tg(itgax-cre)1–1reiz/j
    ( A ) Blood glucose levels in ICR mice with hepatic <t>Ass1</t> knockdown (n = 4 per group). ( B - G ) Plasma levels of urea cycle related amino acids, urea, and ammonia (NH3) in ICR mice with hepatic Ass1 knockdown (n = 4 per group). ( H ) Immunoblot analysis of Ass1 protein using liver total lysate from mice in the fasted state (Samples were pooled from 3 mice). GAPDH was detected as an internal loading control. ( I - Q ) Relative gene expression in ICR mice with hepatic Ass1 knockdown (n = 4 per group). Ass1 knockdown was performed using adenovirus mediated RNAi (Ad- Ass1 i-1, Ad- Ass1 i-2). As the correction of the gene expression level for each sample Cyclophilin A was used. All groups of mice were sacrificed at the same period in the light cycle and blood and liver samples were collected in the fasted state following 24-h fasting. All values are presented as the mean with error bars representing the SEM. Datasets were assessed by Student’s t -test for unpaired samples. The differences were considered to be significant if P < 0.05 (* P < 0.05 and ** P <0.01).
    Mice Expressing A Cre Recombinase Under The Control Of The Itgax Promoter/Enhancer Region B6.Cg Tg(Itgax Cre)1–1reiz/J, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mice expressing a cre recombinase under the control of the itgax promoter/enhancer region b6.cg-tg(itgax-cre)1–1reiz/j/product/Jackson Laboratory
    Average 90 stars, based on 1 article reviews
    mice expressing a cre recombinase under the control of the itgax promoter/enhancer region b6.cg-tg(itgax-cre)1–1reiz/j - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Blood glucose levels in ICR mice with hepatic Ass1 knockdown (n = 4 per group). ( B - G ) Plasma levels of urea cycle related amino acids, urea, and ammonia (NH3) in ICR mice with hepatic Ass1 knockdown (n = 4 per group). ( H ) Immunoblot analysis of Ass1 protein using liver total lysate from mice in the fasted state (Samples were pooled from 3 mice). GAPDH was detected as an internal loading control. ( I - Q ) Relative gene expression in ICR mice with hepatic Ass1 knockdown (n = 4 per group). Ass1 knockdown was performed using adenovirus mediated RNAi (Ad- Ass1 i-1, Ad- Ass1 i-2). As the correction of the gene expression level for each sample Cyclophilin A was used. All groups of mice were sacrificed at the same period in the light cycle and blood and liver samples were collected in the fasted state following 24-h fasting. All values are presented as the mean with error bars representing the SEM. Datasets were assessed by Student’s t -test for unpaired samples. The differences were considered to be significant if P < 0.05 (* P < 0.05 and ** P <0.01).

    Journal: bioRxiv

    Article Title: FoxO transcription factors couple the urea cycle and gluconeogenesis by controlling Ass1

    doi: 10.64898/2025.12.22.695746

    Figure Lengend Snippet: ( A ) Blood glucose levels in ICR mice with hepatic Ass1 knockdown (n = 4 per group). ( B - G ) Plasma levels of urea cycle related amino acids, urea, and ammonia (NH3) in ICR mice with hepatic Ass1 knockdown (n = 4 per group). ( H ) Immunoblot analysis of Ass1 protein using liver total lysate from mice in the fasted state (Samples were pooled from 3 mice). GAPDH was detected as an internal loading control. ( I - Q ) Relative gene expression in ICR mice with hepatic Ass1 knockdown (n = 4 per group). Ass1 knockdown was performed using adenovirus mediated RNAi (Ad- Ass1 i-1, Ad- Ass1 i-2). As the correction of the gene expression level for each sample Cyclophilin A was used. All groups of mice were sacrificed at the same period in the light cycle and blood and liver samples were collected in the fasted state following 24-h fasting. All values are presented as the mean with error bars representing the SEM. Datasets were assessed by Student’s t -test for unpaired samples. The differences were considered to be significant if P < 0.05 (* P < 0.05 and ** P <0.01).

    Article Snippet: The DNA fragment of mouse Ass1 enhancer region containing the FoxO binding site was amplified by PCR using PrimeSTAR GXL DNA Polymerase (Cat#R050A, TaKaRa Bio, Tokyo, Japan), using mouse genomic DNA as template and inserted into multiple cloning site on the pENTR4-Luc Gateway entry vector linked to firefly luciferase reporter with Ass1 native promoter ( Ass1 -Enhancer-Luc) by infusion technique using In-Fusion HD Cloning Kit (Cat#071320, TaKaRa Bio, Tokyo, Japan) according to the manufacturer’s protocol.

    Techniques: Knockdown, Clinical Proteomics, Western Blot, Control, Gene Expression, IF-P

    ( A ) Top, the results of ChIP-seq with anti-FoxO1 antibody in livers of unfed mice obtained from ChIP-Atlas (ID: GSM3381273); bottom, simplified representation of the structure of the full fragment, fragment 1, fragment 2, fragment 3, and the subdivisions of fragment 1 i.e. small fragment 1A and small fragment 1B. ( B and C ) Enhancer analysis of FoxO1 and FoxO3a on Ass1 enhancer and its fragments. FoxO1 and FoxO3a expression plasmids were co-transfected with the indicated Ass1 enhancer firefly luciferase reporter plasmids in HepG2 cells. ( D and E ) Electrophoretic mobility shift assay (EMSA) using radiolabeled probe for ( D ) the two JASPAR predicted FoxO binding sites (Figure S5) in the smallest fragment 1A from the Ass1 enhancer and FoxO binding site in the promoter of Pck1 as a positive control; ( E ) the wild-type (WT) and mutant (Mut) predicted FoxO binding site1 incubated with GST and GST-FoxO recombinant proteins. BS, binding site; WT, wild-type; Mut, mutant. ( F ) Enhancer analysis of FoxO1 and FoxO3a on mutant Ass1 enhancer and its fragments. FoxO1 and FoxO3a expression plasmids were co-transfected with the indicated Ass1 enhancer firefly luciferase reporter plasmids in HepG2 cells. All values are presented as the mean with error bars representing the SEM. Datasets were assessed by Student’s t -test for unpaired samples. The differences were considered to be significant if P < 0.05 (* P < 0.05 and ** P <0.01).

    Journal: bioRxiv

    Article Title: FoxO transcription factors couple the urea cycle and gluconeogenesis by controlling Ass1

    doi: 10.64898/2025.12.22.695746

    Figure Lengend Snippet: ( A ) Top, the results of ChIP-seq with anti-FoxO1 antibody in livers of unfed mice obtained from ChIP-Atlas (ID: GSM3381273); bottom, simplified representation of the structure of the full fragment, fragment 1, fragment 2, fragment 3, and the subdivisions of fragment 1 i.e. small fragment 1A and small fragment 1B. ( B and C ) Enhancer analysis of FoxO1 and FoxO3a on Ass1 enhancer and its fragments. FoxO1 and FoxO3a expression plasmids were co-transfected with the indicated Ass1 enhancer firefly luciferase reporter plasmids in HepG2 cells. ( D and E ) Electrophoretic mobility shift assay (EMSA) using radiolabeled probe for ( D ) the two JASPAR predicted FoxO binding sites (Figure S5) in the smallest fragment 1A from the Ass1 enhancer and FoxO binding site in the promoter of Pck1 as a positive control; ( E ) the wild-type (WT) and mutant (Mut) predicted FoxO binding site1 incubated with GST and GST-FoxO recombinant proteins. BS, binding site; WT, wild-type; Mut, mutant. ( F ) Enhancer analysis of FoxO1 and FoxO3a on mutant Ass1 enhancer and its fragments. FoxO1 and FoxO3a expression plasmids were co-transfected with the indicated Ass1 enhancer firefly luciferase reporter plasmids in HepG2 cells. All values are presented as the mean with error bars representing the SEM. Datasets were assessed by Student’s t -test for unpaired samples. The differences were considered to be significant if P < 0.05 (* P < 0.05 and ** P <0.01).

    Article Snippet: The DNA fragment of mouse Ass1 enhancer region containing the FoxO binding site was amplified by PCR using PrimeSTAR GXL DNA Polymerase (Cat#R050A, TaKaRa Bio, Tokyo, Japan), using mouse genomic DNA as template and inserted into multiple cloning site on the pENTR4-Luc Gateway entry vector linked to firefly luciferase reporter with Ass1 native promoter ( Ass1 -Enhancer-Luc) by infusion technique using In-Fusion HD Cloning Kit (Cat#071320, TaKaRa Bio, Tokyo, Japan) according to the manufacturer’s protocol.

    Techniques: ChIP-sequencing, Expressing, Transfection, Luciferase, Electrophoretic Mobility Shift Assay, Binding Assay, Positive Control, Mutagenesis, Incubation, Recombinant, IF-P

    ( A ) The structure of the Ad-Luc showing the identified FoxO binding site in the enhancer region of Ass1 linked to the Luc reporter using Ass1 native promoter. ( B - F ) In vivo Ad-Luc enhancer analyses using Ad-FoxOBS- Ass1 Promoter-Luc both wild-type and mutant. Representative images ( B ) and hepatic luciferase activities ( C - F ) of mice injected with Ad-FoxOBS- Ass1 Promoter-Luc both wild-type and mutant are shown (n = 5). ( D ) Enhancer activity in the liver for wild-type binding site after 24-h fasting is expressed relative to activity before fasting, to adjust for mouse-to-mouse differences in enhancer expression in Ad-treated mice. ( E ) Enhancer activity in the liver for mutant binding site after 24-h fasting is expressed relative to activity before fasting, to adjust for mouse-to-mouse differences in enhancer expression in Ad-treated mice. ( F ) Enhancer activity in the liver after 24-h fasting for wild-type binding site is expressed relative to activity of mutant binding site, to adjust for mouse-to-mouse differences in enhancer expression in Ad-treated mice. BS, binding site; WT, wild-type; Mut, mutant. Data were assessed using the paired two-tailed Student’s t -test. The differences were considered to be significant if P < 0.05 (** P < 0.01). Error bars mean SEM.

    Journal: bioRxiv

    Article Title: FoxO transcription factors couple the urea cycle and gluconeogenesis by controlling Ass1

    doi: 10.64898/2025.12.22.695746

    Figure Lengend Snippet: ( A ) The structure of the Ad-Luc showing the identified FoxO binding site in the enhancer region of Ass1 linked to the Luc reporter using Ass1 native promoter. ( B - F ) In vivo Ad-Luc enhancer analyses using Ad-FoxOBS- Ass1 Promoter-Luc both wild-type and mutant. Representative images ( B ) and hepatic luciferase activities ( C - F ) of mice injected with Ad-FoxOBS- Ass1 Promoter-Luc both wild-type and mutant are shown (n = 5). ( D ) Enhancer activity in the liver for wild-type binding site after 24-h fasting is expressed relative to activity before fasting, to adjust for mouse-to-mouse differences in enhancer expression in Ad-treated mice. ( E ) Enhancer activity in the liver for mutant binding site after 24-h fasting is expressed relative to activity before fasting, to adjust for mouse-to-mouse differences in enhancer expression in Ad-treated mice. ( F ) Enhancer activity in the liver after 24-h fasting for wild-type binding site is expressed relative to activity of mutant binding site, to adjust for mouse-to-mouse differences in enhancer expression in Ad-treated mice. BS, binding site; WT, wild-type; Mut, mutant. Data were assessed using the paired two-tailed Student’s t -test. The differences were considered to be significant if P < 0.05 (** P < 0.01). Error bars mean SEM.

    Article Snippet: The DNA fragment of mouse Ass1 enhancer region containing the FoxO binding site was amplified by PCR using PrimeSTAR GXL DNA Polymerase (Cat#R050A, TaKaRa Bio, Tokyo, Japan), using mouse genomic DNA as template and inserted into multiple cloning site on the pENTR4-Luc Gateway entry vector linked to firefly luciferase reporter with Ass1 native promoter ( Ass1 -Enhancer-Luc) by infusion technique using In-Fusion HD Cloning Kit (Cat#071320, TaKaRa Bio, Tokyo, Japan) according to the manufacturer’s protocol.

    Techniques: Binding Assay, In Vivo, Mutagenesis, Luciferase, Injection, Activity Assay, Expressing, Two Tailed Test, IF-P

    ( A - D ) Chromatin immunoprecipitation (ChIP) assay to determine the interaction of hepatic FoxO proteins with Ass1 DNA enhancer region using anti-FoxO1 antibody and normal mouse anti-IgG antibody as a control. ( E - H ) Chromatin immunoprecipitation (ChIP) assay to determine the interaction of hepatic FoxO proteins with Ass1 DNA enhancer region using anti-FoxO3a antibody and normal mouse anti-IgG antibody as a control. ( A , E ) FoxO proteins binding to Ass1 enhancer in liver detected by using primer set designed around the identified FoxO binding site in . ( B , F ) Pck1 promoter FoxO transcription factor binding site and ( C , G ) G6pc promoter FoxO transcription factor binding site used as a positive control. ( D , H ) Used as a negative control. ( I ) Immunoblot analysis of FoxO1 and FoxO3a proteins using liver nuclear extracts from mice in ad libitum-fed and fasted state (Samples were pooled from 3 mice). Lamin A/C was detected as an internal loading control for nuclear protein. All groups of mice were sacrificed in the light cycle and liver samples were collected in the fasted state following 24-h fasting or ad libitum-fed as indicated. Data were assessed using the unpaired two-tailed Student’s t -test. The differences were considered to be significant if P < 0.05 (** P < 0.01). Error bars mean SEM.

    Journal: bioRxiv

    Article Title: FoxO transcription factors couple the urea cycle and gluconeogenesis by controlling Ass1

    doi: 10.64898/2025.12.22.695746

    Figure Lengend Snippet: ( A - D ) Chromatin immunoprecipitation (ChIP) assay to determine the interaction of hepatic FoxO proteins with Ass1 DNA enhancer region using anti-FoxO1 antibody and normal mouse anti-IgG antibody as a control. ( E - H ) Chromatin immunoprecipitation (ChIP) assay to determine the interaction of hepatic FoxO proteins with Ass1 DNA enhancer region using anti-FoxO3a antibody and normal mouse anti-IgG antibody as a control. ( A , E ) FoxO proteins binding to Ass1 enhancer in liver detected by using primer set designed around the identified FoxO binding site in . ( B , F ) Pck1 promoter FoxO transcription factor binding site and ( C , G ) G6pc promoter FoxO transcription factor binding site used as a positive control. ( D , H ) Used as a negative control. ( I ) Immunoblot analysis of FoxO1 and FoxO3a proteins using liver nuclear extracts from mice in ad libitum-fed and fasted state (Samples were pooled from 3 mice). Lamin A/C was detected as an internal loading control for nuclear protein. All groups of mice were sacrificed in the light cycle and liver samples were collected in the fasted state following 24-h fasting or ad libitum-fed as indicated. Data were assessed using the unpaired two-tailed Student’s t -test. The differences were considered to be significant if P < 0.05 (** P < 0.01). Error bars mean SEM.

    Article Snippet: The DNA fragment of mouse Ass1 enhancer region containing the FoxO binding site was amplified by PCR using PrimeSTAR GXL DNA Polymerase (Cat#R050A, TaKaRa Bio, Tokyo, Japan), using mouse genomic DNA as template and inserted into multiple cloning site on the pENTR4-Luc Gateway entry vector linked to firefly luciferase reporter with Ass1 native promoter ( Ass1 -Enhancer-Luc) by infusion technique using In-Fusion HD Cloning Kit (Cat#071320, TaKaRa Bio, Tokyo, Japan) according to the manufacturer’s protocol.

    Techniques: Chromatin Immunoprecipitation, Control, Binding Assay, Positive Control, Negative Control, Western Blot, Two Tailed Test, IF-P